ReviewFrontiers in oncology2015
Thoracic Wall Reconstruction after Tumor Resection.
Review in Frontiers in oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 61 citations in OpenAlex.
- A practical strategy for skeletal chest wall reconstruction after resection of malignant chest wall lesions: a single-institution experience.Surgery today · 2026Article
- Oncological Reconstruction of the Anterior Chest Wall in a Resource-limited Setting.Plastic and reconstructive surgery. Global open · 2026Article
- The Long-Term Quality of Life Study for Patients Received Chest Wall Reconstruction by Using 3D-Printed PEEK Implants.Thoracic cancer · 2026Article
- Narrative review: a multidisciplinary approach to chest wall reconstruction.Journal of thoracic disease · 2026Review
- Article
- Clinical and surgical outcome following chest wall reconstruction using a novel rigid prosthesis-a single-center experience.Journal of thoracic disease · 2025Article
- Innovative Technique of Chest Wall Reconstruction After Extensive Tumour Ablation Surgery.Indian journal of surgical oncology · 2024Article
- Chest wall reconstruction, prosthesis and allografts: a narrative review.Journal of thoracic disease · 2023Review
- Interdisciplinary Treatment of Malignant Chest Wall Tumors.Journal of personalized medicine · 2023Article
- [Perforator-based keystone flap in the reconstruction of extensive tissue defects after lumbosacral spondylodesis].Unfallchirurgie (Heidelberg, Germany) · 2022Article
- Chest-Wall Tumors and Surgical Techniques: State-of-the-Art and Our Institutional Experience.Journal of clinical medicine · 2022Review
- Article
- Operative Planning of Chest Wall Reconstructions Illustrated by a Large Defect in a Child.Plastic and reconstructive surgery. Global open · 2022Article
- The sternum reconstruction: Present and future perspectives.Frontiers in oncology · 2022Review
- Giant bleeding post-traumatic thoracic sarcoma management: A case report.Frontiers in surgery · 2022Article
- Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group.Journal of clinical medicine · 2021Article
- A South American Experience With Postoperative Complications Following Chest Wall Reconstruction for Neoplasms.World journal of surgery · 2021Article
- Relapsing phyllodes cystosarcoma and chest wall invasion with long-term survival: is aggressive surgery worthwhile?Indian journal of thoracic and cardiovascular surgery · 2021Article
- Chest wall resection and reconstruction: a case series of 20 patients in Hospital Kuala Lumpur, Malaysia.Indian journal of thoracic and cardiovascular surgery · 2021Article
- [Soft tissue defects following tumor resection in the limbs and trunk : Plastic reconstructive soft tissue and revision concepts].Der Orthopade · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSurgical treatment of malignant thoracic wall tumors represents a formidable challenge. In particular, locally advanced tumors that have already infiltrated critical anatomic structures are associated with a high surgical morbidity and can result in full-thickness defects of the thoracic wall. Plastic surgery can reduce this surgical morbidity by reconstructing the thoracic wall through various tissue transfer techniques. Sufficient soft-tissue reconstruction of the thoracic wall improves quality of life and mitigates functional impairment after extensive resection. The aim of this article is to illustrate the various plastic surgery treatment options in the multimodal therapy of patients with malignant thoracic wall tumors. MATERIALS AND
methodsThis article is based on a review of the current literature and the evaluation of a patient database.
resultsSeveral plastic surgical treatment options can be implemented in the curative and palliative therapy of patients with malignant solid tumors of the chest wall. Large soft-tissue defects after tumor resection can be covered by local, pedicled, or free flaps. In cases of large full-thickness defects, flaps can be combined with polypropylene mesh to improve chest wall stability and to maintain pulmonary function. The success of modern medicine has resulted in an increasing number of patients with prolonged survival suffering from locally advanced tumors that can be painful, malodorous, or prone to bleeding. Resection of these tumors followed by thoracic wall reconstruction with viable tissue can substantially enhance the quality of life of these patients. DISCUSSION: In curative treatment regimens, chest wall reconstruction enables complete resection of locally advanced tumors and subsequent adjuvant radiotherapy. In palliative disease treatment, plastic surgical techniques of thoracic wall reconstruction provide palliation of tumor-associated morbidity and can therefore improve patients' quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.